Materials and Methods Participants The current study protocol was approved by the Institutional Review Board at the University of North Texas and all aspects of the study were conducted in accordance with the Declaration of Helsinki
Wegovy and Zepbound may also have different formulary placements within the same plan
It is commonly included in physician-directed protocols for patients with diabetes, cardiovascular disease, or age-related toxin buildup that can lead to arterial thickening and reduced blood flow, particularly in adults over age 50
Ferrous Fumarate: Gastrointestinal disturbances (anorexia, nausea, diarrhea, constipation, heartburn, and vomiting) occur occasionally, but are usually mild and may subside with continuation of therapy
This was confirmed in early dose-response studies by Svensson et al